Flow cytometry analysis of peripheral Tregs in patients with multiple myeloma under lenalidomide maintenance

Int J Hematol. 2021 May;113(5):772-774. doi: 10.1007/s12185-021-03093-y. Epub 2021 Feb 8.

¹ Department of Hematology and Oncology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. knozaki@bldon.med.osaka-u.ac.jp.
² Department of Hematology Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.
³ Division of Cancer Immunology, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan.
⁴ Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
⁵ Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
⁶ Department of Hematology, Kawasaki Hospital, Kobe, Japan.
⁷ Ikeda City Hospital, Ikeda, Japan.
⁸ Department of Internal Medicine (Hematology), Toyonaka Municipal Hospital, Toyonaka, Japan.
⁹ Department of Hematology and Oncology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan.

No abstract available

Keywords: Flow cytometry; Lenalidomide; Multiple myeloma; Regulatory T cells.

Publication types